 Adaptimmune Therapeutics plc NASDAQ:ADAP Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Juli Miller Head-Investor Relations Adrian Rawcliffe Chief Executive Officer Gavin Wood Chief Financial Officer Helen Tayton-Martin Chief Business Officer John Lunger Chief Patient Supply Officer Elliot Norry Chief Medical Officer Cintia Piccina Chief Commercial Officer Conference Call Participants Marc Frahm Cowen and Company Tony Butler ROTH Capital Faisal Khurshid SVB Securities Nick Abbott Wells Fargo Mara Goldstein Mizuho Operator Good morning and thank you for standing by. Welcome to the First Quarter 2022 Adaptimmune Earnings Conference Call. 